A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes

Infection and Immunity

Volumn 83, Issue 6, 2015, Pages 2264-2274

  Farnsworth, Christopher W ^a   Shehatou, Cindy T ^a   Maynard, Robert ^a   Nishitani, Kohei ^a   Kates, Stephen L ^a   Zuscik, Michael J ^a   Schwarz, Edward M ^a   Daiss, John L ^a   Mooney, Robert A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPLASTY; ARTICLE; BIOLUMINESCENCE; BONE IMPLANT; BONE INFECTION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DEVICE INFECTION; DISEASE SEVERITY; GENE REARRANGEMENT; HUMAN; HUMORAL IMMUNE DEFICIENCY; HUMORAL IMMUNITY; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORTHOPEDIC IMPLANT; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE INTOLERANCE; IMMUNOLOGY; MICROBIOLOGY; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS;

ADAPTIVE IMMUNITY; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HUMANS; IMMUNITY, HUMORAL; MALE; MICE; MICE, INBRED C57BL; OBESITY; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84929484410     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.03074-14     Document Type: Article

References (37)

1. Jamsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. 2012. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 94:e101. http://dx.doi.org/10.2106/JBJS.J.01935.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. 2007. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780-785. http://dx.doi.org/10.2106/JBJS.F.00222.
3. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. 2008. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 23:984-991. http://dx.doi.org/10.1016/j.arth.2007.10.017.
4. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. 2012. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA 308:1227-1236. http://dx.doi.org/10.1001/2012.jama.11153.
5. Wright JA, Nair SP. 2010. Interaction of staphylococci with bone. Int J Med Microbiol 300:193-204. http://dx.doi.org/10.1016/j.ijmm.2009.10.003.
6. Lew DP, Waldvogel FA. 2004. Osteomyelitis. Lancet 364:369-379. http://dx.doi.org/10.1016/S0140-6736(04)16727-5.
7. Uckay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. 2009. Foreign body infections due to Staphylococcus epidermidis. Ann Med 41: 109-119. http://dx.doi.org/10.1080/07853890802337045.
8. Mooney RA, Sampson ER, Lerea J, Rosier RN, Zuscik MJ. 2011. High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury. Arthritis Res Ther 13:R198. http://dx.doi.org/10.1186/ar3529.
9. Del Pozo JL, Patel R. 2009. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 361:787-794. http://dx.doi.org/10.1056/NEJMcp0905029.
10. Dowsey MM, Choong PF. 2009. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 467: 1577-1581. http://dx.doi.org/10.1007/s11999-008-0551-6.
11. Wu C, Qu X, Liu F, Li H, Mao Y, Zhu Z. 2014. Risk factors for periprosthetic joint infection after total hip arthroplasty and total knee arthroplasty in Chinese patients. PLoS One 9:e95300. http://dx.doi.org/10.1371/journal.pone.0095300.
12. Klein EY, Sun L, Smith DL, Laxminarayan R. 2013. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol 177:666-674. http://dx.doi.org/10.1093/aje/kws273.
13. Yano H, Kinoshita M, Fujino K, Nakashima M, Yamamoto Y, Miyazaki H, Hamada K, Ono S, Iwaya K, Saitoh D, Seki S, Tanaka Y. 2012. Insulin treatment directly restores neutrophil phagocytosis and bactericidal activity in diabetic mice and thereby improves surgical site Staphylococcus aureus infection. Infect Immun 80:4409-4416. http://dx.doi.org/10.1128/IAI.00787-12.
14. Park S, Rich J, Hanses F, Lee JC. 2009. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun 77:1008-1014. http://dx.doi.org/10.1128/IAI.00976-08.
15. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S. 2007. Dietinduced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci USA 104: 20466-20471. http://dx.doi.org/10.1073/pnas.0710335105.
16. Lee MS, Kwon HJ, Kim HS. 2012. Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway. J Clin Immunol 32:753-761. http://dx.doi.org/10.1007/s10875-012-9682-3.
17. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, Markham D, Strissel KJ, Watkins AA, Zhu M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS. 2013. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 110:5133-5138. http://dx.doi.org/10.1073/pnas.1215840110.
18. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG. 2011. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17:610-617. http://dx.doi.org/10.1038/nm.2353.
19. Wang Y, Hao L, Gill RG, Lafferty KJ. 1987. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36:535-538. http://dx.doi.org/10.2337/diab.36.4.535.
20. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, Holland LA, Weir S, Noah TL, Beck MA. 2012. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes 36:1072-1077. http://dx.doi.org/10.1038/ijo.2011.208.
21. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. 2006. Reduced tetanus antibody titers in overweight children. Autoimmunity 39: 137-141. http://dx.doi.org/10.1080/08916930600597326.
22. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. 1988. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167. http://dx.doi.org/10.2337/diabetes.37.9.1163.
23. Mansford KR, Opie L. 1968. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet i:670-671.
24. Ventura-Sobrevilla J, Boone-Villa VD, Aguilar CN, Roman-Ramos R, Vega-Avila E, Campos-Sepulveda E, Alarcon-Aguilar F. 2011. Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. Proc West Pharmacol Soc 54:5-9.
25. Leiter EH. 1982. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc Natl Acad Sci USA 79:630-634. http://dx.doi.org/10.1073/pnas.79.2.630.
26. Li D, Gromov K, Soballe K, Puzas JE, O'Keefe RJ, Awad H, Drissi H, Schwarz EM. 2008. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res 26:96-105. http://dx.doi.org/10.1002/jor.20452.
27. Junod A, Lambert AE, Stauffacher W, Renold AE. 1969. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48:2129-2139. http://dx.doi.org/10.1172/JCI106180.
28. Lovati AB, Drago L, Monti L, De Vecchi E, Previdi S, Banfi G, Romano CL. 2013. Diabetic mouse model of orthopaedic implant-related Staphylococcus aureus infection. PLoS One 8:e67628. http://dx.doi.org/10.1371/journal.pone.0067628.
29. Olsen K, Danielsen K, Wilsgaard T, Sangvik M, Sollid JU, Thune I, Eggen AE, Simonsen GS, Furberg AS. 2013. Obesity and Staphylococcus aureus nasal colonization among women and men in a general population. PLoS One 8:e63716. http://dx.doi.org/10.1371/journal.pone.0063716.
30. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. 1987. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10:483-486. http://dx.doi.org/10.2337/diacare.10.4.483.
31. Zhou Q, Leeman SE, Amar S. 2009. Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. Proc Natl Acad Sci USA 106:10740-10745. http://dx.doi.org/10.1073/pnas.0904412106.
32. Kumar M, Roe K, Nerurkar PV, Namekar M, Orillo B, Verma S, Nerurkar VR. 2012. Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS One 7:e44682. http://dx.doi.org/10.1371/journal.pone.0044682.
33. Fried AJ, Bonilla FA. 2009. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 22:396-414. http://dx.doi.org/10.1128/CMR.00001-09.
34. Wood P, UK Primary Immunodeficiency Network. 2009. Primary antibody deficiencies: recognition, clinical diagnosis and referral of patients. Clin Med 9:595-599. http://dx.doi.org/10.7861/clinmedicine.9-6-595.
35. Bridgeford EC, Fox JG, Nambiar PR, Rogers AB. 2008. Agammaglobulinemia and Staphylococcus aureus botryomycosis in a cohort of related sentinel Swiss-Webster mice. J Clin Microbiol 46:1881-1884. http://dx.doi.org/10.1128/JCM.01875-07.
36. Gregor MF, Hotamisligil GS. 2011. Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415-445. http://dx.doi.org/10.1146/annurev-immunol-031210-101322.
37. Frasca D, Romero M, Diaz A, Alter-Wolf S, Ratliff M, Landin AM, Riley RL, Blomberg BB. 2012. A molecular mechanism for TNF-alphamediated downregulation of B cell responses. J Immunol 188:279-286. http://dx.doi.org/10.4049/jimmunol.1003964.